
    
      August-1 is a register to find out to which extent RCT patients are representative for the
      overall patient collective with dfs and critical limb ischemia and to evaluate the
      therapeutic success of other treatment strategies. An RCT to assess the efficacy of urokinase
      versus placebo is imbedded in the register.
    
  